Navigation Links
Dyadic Netherlands To Develop Baking Enzymes For EU-Funded Research Project
Date:9/5/2012

JUPITER, Fla. and WAGENINGEN, Netherlands, Sept. 5, 2012 /PRNewswire/ -- Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the industrial enzyme, bioenergy, bio-based chemical and biopharmaceutical industries, announced today that its research and development center in the Netherlands is a participant in the HealthBread Project, a new multidisciplinary research program that has been awarded approximately one million Euro from the European Community's Seventh Framework Programme (FP7).

The HealthBread Project is a two year research program whose objective is to develop whole grain and white breads with improved nutritional value, taste and product quality by applying scientific and technological knowledge to the production and marketing of commercially viable, healthier bread. Dyadic Netherlands will receive approximately 143,000 Euro to develop commercial enzymes for the HealthBread Project which is scheduled to begin in October 2012.

Wim van der Wilden, the General Manager of Dyadic Netherlands, stated, "In continuing to enhance Dyadic's technologies and products for food applications, we are excited to work with leading scientific, baking and food organizations to demonstrate the effectiveness of Dyadic's C1 enzyme technology in producing healthier and more nutritious bread products. The value of these types of research programs is that they allow Dyadic to use and further enhance our technologies for specific enzyme applications in collaboration with leading organizations which can potentially lead to new sales and licensing opportunities."

The Netherlands Organization for Applied Scientific Research (TNO) will serve as the coordinator of the HealthBread Project which, in addition to Dyadic Netherlands, consists of the following research organizations, bakeries and large ingredient suppliers:'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dyadic International to Announce Second Quarter 2012 Financial Results and Host Conference Call on Monday, August 13, 2012
2. Dyadic Demonstrates Industry-leading Biofuels Enzyme Performance
3. Dyadic International To Release First Quarter 2012 Financial Results And Host Conference Call
4. Dyadic International Launches FibreZyme® G5000 High Performance Powder Pulp and Paper Enzyme in Booth #1065 at Tissue World Americas Conference
5. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
6. Allergan Opens New Research and Development Center in Bridgewater, New Jersey
7. ESTEVE Announces the Publication of Comprehensive Phase I Data for a Novel Oral, First-in-class New Chemical Entity (NCE),E-52862, a Sigma-1 Receptor Antagonist (S1RA) Being Developed for Pain
8. Carnegie Mellons Jeffrey Hollinger Leads Research Team Developing New Tools To Ease Pain of Combat Injuries
9. New model of muscular dystrophy provides insight into disease development
10. New wave of technologies possible after ground-breaking analysis tool developed
11. IBN develops superior fuel cell material
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 2014 The chemistry, taste, and health effects of ... article published by the nonprofit American Botanical Council (ABC). Recent ... and its effects on the phytochemical compounds in tea ( ... by Dr. Ahmed in the Yunnan ... implications for the future of medicinal botanicals. Dr. Ahmed,s ...
(Date:9/15/2014)... 15. September 2014 Die zweite jährliche ... vom 12. bis 18. Oktober stattfinden. Die IPAW ... Therapeutics Association (PPTA) und ihrer Mitgliedsunternehmen ... Das globale Bewusstsein für die Gewinnung von Quellplasma ... beim Retten und Verbessern von Leben zu würdigen ...
(Date:9/15/2014)... , 15 de septiembre de 2014 La segunda ... a cabo del 12 al 18 de octubre. Como iniciativa ... y de sus compañías miembro s, la IPAW se ... mundial en torno a la colección de fuentes de plasma ... plasma al salvar y mejorar las vidas , Aumento ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Hydro ... ) announced today that it will be partnering ... CA ( http://www.proteaf.com ) for implementing its Shock ... value continuous processing. Continuous flow chemistry through ... chemical, pharmaceutical and petrochemical markets for decades. ...
Breaking Biology Technology:Tea Taste and Quality Affected by Climate Change 2Tea Taste and Quality Affected by Climate Change 3Tea Taste and Quality Affected by Climate Change 4International Plasma Awareness Week feiert Spender und rückt seltene Krankheiten in den Mittelpunkt 2International Plasma Awareness Week feiert Spender und rückt seltene Krankheiten in den Mittelpunkt 3La International Plasma Awareness Week será una celebración para los donantes 2La International Plasma Awareness Week será una celebración para los donantes 3Hydro Dynamics Partners with the Continuous Flow Chemistry Experts of Proteaf Technologies 2
... Ohio -- In the quest for smaller, faster computer ... the exotic physics of the small. The problem: ... been equally exotic. That is, until now. ... to make quantum devices using technology common to the ...
... 15 Today, Formatech, Inc. announced that ... HIV/AIDS vaccine will be the first clinical candidate that is ... run is scheduled to be completed in January 2010. ... aseptically fill and finish one lot of the vaccine for ...
... 15 SIRO Clinpharm, a global Contract Research Organization (CRO) ... announced expansion of its Clinical Trials Supplies facility in Mumbai, ... pharmaceutical and biotech companies for storage and distribution of clinical ... , "We opened our clinical trials supplies warehouse ...
Cached Biology Technology:Quantum computer chips now 1 step closer to reality 2Quantum computer chips now 1 step closer to reality 3Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its 'Fillanthropy(TM) Program' 2Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its 'Fillanthropy(TM) Program' 3Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its 'Fillanthropy(TM) Program' 4SIRO Clinpharm Strengthens its Clinical Trials Supplies Service Offering in India 2
(Date:9/15/2014)... Globally, cardiovascular disease (CVD) claims 17 million lives each ... additional 9.4 million. 1 New research presented by ... in Montpellier, France on September 15, 2014, suggests that ... , At the Milk and Dairy Products ... and risk for hypertension and CVD was examined by ...
(Date:9/15/2014)... the need for vitamin E and how much is ... levels of this essential micronutrient are especially critical for ... or may become pregnant. , A lifelong proper intake ... often complicated by the fact that this nutrient is ... alone. It has been estimated that only a tiny ...
(Date:9/12/2014)... DUBLIN, Ireland , September 12, 2014 ... and Markets ( http://www.researchandmarkets.com/research/trs4c7/global ) has announced ... Lock Industry Report 2014" report to ... Fingerprint Lock Industry Report 2014 is a ... state of the global fingerprint lock industry. ...
Breaking Biology News(10 mins):Dairy consumption linked to lower blood pressure and cardiovascular disease risk 2Vitamin E intake critical during 'the first 1,000 days' 2Vitamin E intake critical during 'the first 1,000 days' 3Global Fingerprint Lock Industry Report 2014 2
... Spanish . Losses of managed honey bee ... 2009 to April 2010, according to a survey conducted by ... Service (ARS). Beekeepers identified starvation, poor weather, and weak colonies ... their operations. This is an increase from overall losses ...
... cognitive decline and for preventing Alzheimer,s diseasemental stimulation, ... studied over the years. However, an independent panel ... Health determined that the value of these strategies ... of decline or disease hasn,t been demonstrated in ...
... research team has taken a major step forward in understanding ... immune response by combining nanotechnology and cell biology. T cells ... response to infection. Christopher Cairo and his team ... cell response is switched on. Cairo looked at the molecule ...
Cached Biology News:Survey reports latest honey bee losses 2Panel finds insufficient evidence for Alzheimer's disease preventive measures 2Panel finds insufficient evidence for Alzheimer's disease preventive measures 3U Alberta-led team studies T cell activation with nanoparticles 2
4-Hydroxy-3-nitrophenylacetyl hapten is conjugated to KLH (Keyhole Limpet Hemocyanin) lysine through amide bonds....
Estrogen Receptor (ER) Competitor Assay Kits Green for Estrogen Receptors-alpha and -beta (ER-Alpha and ER-Beta) are ideal for screening novel estrogen receptor binding compounds and endocrine disrup...
Human Aminopeptidase P2/XPNPEP2 Affinity Purified PAb ENTREZ GeneID: 7512...
in vitro Translation, Accessory Products...
Biology Products: